标题:p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells
作者:Zhang, Ding-Guo;Zhang, Jinling;Mao, Lin-Lin;Wu, Jin-Xia;Cao, Wen-Jia;Zheng, Jun-Nian;Pei, Dong-Sheng
作者机构:[Zhang, D.-G] Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, 84 West Huai-hai Road, Xuzhou, 221002, China;[ Zhang, J] Li 更多
通讯作者:Zheng, JN
通讯作者地址:[Zheng, JN]Affiliated Hosp, Xuzhou Med Coll, Ctr Clin Oncol, Xuzhou 221002, Peoples R China.
来源:Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine
出版年:2015
卷:36
期:5
页码:3685-3691
DOI:10.1007/s13277-014-3007-5
关键词:p21-Activated kinase 5;Apoptosis;Cell cycle arrest;p-chk2;Cisplatin;Hepatocellular carcinoma
摘要:p21-Activated kinase 5 (PAK5) is the last identified member of the PAK family. The PAKs are highly conserved serine/threonine and effector proteins for Cdc42 and Rac and are essential in regulating cell motility and survival. Previous studies have demonstrated that PAK5 played a pivotal role in apoptosis, proliferation, cancer migration, and invasion. However, the biological function of PAK5 in hepatocellular carcinoma, as well as its underlying mechanism, still remains to be fully elucidated. In the present study, we demonstrated that PAK5 markedly inhibited cisplatin-induced apoptosis and promoted cell proliferation in hepatocellular carcinoma cells. Moreover, our results showed that overexpression of PAK5 contributed to cell cycle regulation. In order to elucidate the underlying mechanism of PAK5 on cisplatin-induced apoptosis and cell cycle regulation, we also examined the protein expressions of chk2 and p-chk2. In summary, our study investigated the role of PAK5 in cisplatin-induced cellular processes and provided evidence of its underlying mechanism.
收录类别:SCOPUS;SCIE
WOS核心被引频次:4
Scopus被引频次:4
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929957597&doi=10.1007%2fs13277-014-3007-5&partnerID=40&md5=a9878530a4a2df3f9b17ce567ddf2a43
TOP